Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung Hee Lim

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 11, 2026
Exploring the Immune Microenvironment for Predicting Immunotherapy Efficacy in Epstein-Barr Virus-Associated Gastric CancerYunjoo Cho, Sung Hee Lim, Seung Tae Kim, et al.
Anticancer Research|August 30, 2023
Pemetrexed and Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer Who Failed Gemcitabine-containing Chemotherapy: A Phase II Single-arm Prospective StudySung Hee Lim, Jung Yong Hong, Joon Oh Park, et al.
Neurocase|February 9, 2016
Recovery of language function in Korean-Japanese crossed bilingual aphasia following right basal ganglia hemorrhageBoram Lee, Hyun Im Moon, Sung Hee Lim, et al.
Cancer Immunology, Immunotherapy : CII|March 31, 2026
Mass cytometry uncovers distinct blood myeloid phenotypes linked to clinical responses during gastric cancer chemoimmunotherapySung Hee Lim, Minae An, You Jeong Heo, et al.
Expert Opinion on Biological Therapy|January 23, 2016
Pembrolizumab for the treatment of non-small cell lung cancerSung Hee Lim, Jong-Mu Sun, Se-Hoon Lee, et al.
Cancer Research and Treatment|March 13, 2015
Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the Effect of Host Status, Tumor Burden, and Inflammatory Activity on Venous ThromboembolismSung Hee Lim, Sook-Young Woo, Seonwoo Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21Sung Hee Lim, Ji Yun Lee, Jong-Mu Sun, et al.
Frontiers in Oncology|October 15, 2024
TAS-102 (trifluridine/tipiracil) plus bevacizumab versus TAS-102 alone as salvage treatment options for metastatic colorectal cancer in routine clinical practiceJi Eun Shin, Sung Hee Lim, Jeeyun Lee, et al.
Cancers|September 14, 2024
The Impact of Pembrolizumab as a Salvage Therapy Based on HER2 Expression in Advanced Gastric CancerSung Hee Lim, Min Jung Kim, Jeeyun Lee, et al.
Acta Haematologica|October 18, 2014
Pilot trial of systemic methotrexate plus R-CHOP regimen with intrathecal methotrexate for simultaneous central nervous system and systemic diffuse large B cell lymphomaKwai Han Yoo, Ji Yun Lee, Sung Hee Lim, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 11, 2026
Exploring the Immune Microenvironment for Predicting Immunotherapy Efficacy in Epstein-Barr Virus-Associated Gastric CancerYunjoo Cho, Sung Hee Lim, Seung Tae Kim, et al.
Anticancer Research|August 30, 2023
Pemetrexed and Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer Who Failed Gemcitabine-containing Chemotherapy: A Phase II Single-arm Prospective StudySung Hee Lim, Jung Yong Hong, Joon Oh Park, et al.
Neurocase|February 9, 2016
Recovery of language function in Korean-Japanese crossed bilingual aphasia following right basal ganglia hemorrhageBoram Lee, Hyun Im Moon, Sung Hee Lim, et al.
Cancer Immunology, Immunotherapy : CII|March 31, 2026
Mass cytometry uncovers distinct blood myeloid phenotypes linked to clinical responses during gastric cancer chemoimmunotherapySung Hee Lim, Minae An, You Jeong Heo, et al.
Expert Opinion on Biological Therapy|January 23, 2016
Pembrolizumab for the treatment of non-small cell lung cancerSung Hee Lim, Jong-Mu Sun, Se-Hoon Lee, et al.
Cancer Research and Treatment|March 13, 2015
Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the Effect of Host Status, Tumor Burden, and Inflammatory Activity on Venous ThromboembolismSung Hee Lim, Sook-Young Woo, Seonwoo Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21Sung Hee Lim, Ji Yun Lee, Jong-Mu Sun, et al.
Frontiers in Oncology|October 15, 2024
TAS-102 (trifluridine/tipiracil) plus bevacizumab versus TAS-102 alone as salvage treatment options for metastatic colorectal cancer in routine clinical practiceJi Eun Shin, Sung Hee Lim, Jeeyun Lee, et al.
Cancers|September 14, 2024
The Impact of Pembrolizumab as a Salvage Therapy Based on HER2 Expression in Advanced Gastric CancerSung Hee Lim, Min Jung Kim, Jeeyun Lee, et al.
Acta Haematologica|October 18, 2014
Pilot trial of systemic methotrexate plus R-CHOP regimen with intrathecal methotrexate for simultaneous central nervous system and systemic diffuse large B cell lymphomaKwai Han Yoo, Ji Yun Lee, Sung Hee Lim, et al.
Pageof 11